 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1821 - 1830 of 2187:
People's Pharmacy: Does FDA OK give pharmacies a free pass?
Does Food and Drug Administration approval guarantee safety? If the Supreme Court rules as expected, patients might have no legal recourse if they are...
Permanent Injunction against Two Drug obtained by FDA
The Food and Drug Administration recently announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, M...
Permanent injunction Halts Westminster firm's sale of 50 drugs
A permanent injunction is won by the federal regulators this week barring a Westminster drug company and its New Jersey parent from selling more than ...
Pet-health and Safety widget Launched by FDA
A widget that can help distribute user-friendly public-health information has been launched by The U.S. Food and Drug Administration. For the non-tech...
PetSmart Recalls Biscuits after FDA Warning
In response to the Food and Drug Administration's recall of peanut butter products after determining a nationwide Salmonella Typhimurium outbreak, Pet...
Pfizer Alerted by FDA for not reporting side effects
FDA issued a 12-page warning letter to Pfizer Chief Executive Jeffrey Kindler and cited the numerous examples involving some of the company's top-know...
Pfizer Defends Epilepsy Drugs Before FDA Panel
Drug giant Pfizer Inc. (PFE) on Thursday defended its epilepsy drugs, telling federal regulators and medical experts the drugs minimally increase the ...
Pfizer gets FDA request on osteoporosis drug
Pfizer Inc. said Friday the Food and Drug Administration asked for more information on its developing osteoporosis drug lasofoxifene. The agency is cu...
Pfizer Receives FDA Complete Response Letter for Lasofoxifene
Pfizer Inc said today it has received a complete response letter from the U.S. Food and Drug Administration (FDA) asking for additional information on...
Pfizer Sill Waiting For FDA's Approval
The European Union couple of days back approved Pfizer's and Ligand Pharmaceuticals' osteoporosis drug, Fablyn, after the EU drug panel had given a p... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |